Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpoints

被引:0
|
作者
Kirchner, Marietta [1 ]
Schuepke, Stefanie [2 ,3 ,4 ]
Kieser, Meinhard [1 ,5 ]
机构
[1] Heidelberg Univ, Inst Med Biometry, Heidelberg, Germany
[2] Privatpraxis Kardiol, Frankfurt, Germany
[3] Deutsch Herzzentrum Munich, ISARes Ctr, Munich, Germany
[4] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Berlin, Germany
[5] Heidelberg Univ, Inst Med Biometry, Im Neuenheimer Feld 130 3, D-69120 Heidelberg, Germany
关键词
allocation ratio; clinical trial; power; sample size; UNEQUAL RANDOMIZATION; CLINICAL-TRIALS;
D O I
10.1002/pst.2375
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The sample size of a clinical trial has to be large enough to ensure sufficient power for achieving the aim the study. On the other side, for ethical and economical reasons it should not be larger than necessary. The sample size allocation is one of the parameters that influences the required total sample size. For two-arm superiority and non-inferiority trials with binary endpoints, we performed extensive computations over a wide range of scenarios to determine the optimal allocation ratio that minimizes the total sample size if all other parameters are fixed. The results demonstrate, that for both superiority and non-inferiority trials the optimal allocation may deviate considerably from the case of equal sample size in both groups. However, the saving in sample size when allocating the total sample size optimally as compared to balanced allocation is typically small.
引用
收藏
页码:678 / 686
页数:9
相关论文
共 50 条
  • [1] Blinded sample size reestimation in non-inferiority trials with binary Endpoints
    Friede, Tim
    Mitchell, Charles
    Mueller-Velten, Guenther
    BIOMETRICAL JOURNAL, 2007, 49 (06) : 903 - 916
  • [2] Bayesian sample size determination in a three-arm non-inferiority trial with binary endpoints
    Tang, Niansheng
    Yu, Bin
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2022, 32 (05) : 768 - 788
  • [3] Reducing sample size by combining superiority and non-inferiority for two primary endpoints in the Social Fitness study
    Donkers, Hanneke
    Graff, Maud
    Vemooij-Dassen, Myrra
    Nijhuis-van der Sanden, Maria
    Teerenstra, Steven
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2017, 81 : 86 - 95
  • [4] Planning and analysis of three-arm non-inferiority trials with binary endpoints
    Kieser, Meinhard
    Friede, Tim
    STATISTICS IN MEDICINE, 2007, 26 (02) : 253 - 273
  • [5] Blinded Sample Size Reestimation with Negative Binomial Counts in Superiority and Non-inferiority Trials
    Friede, T.
    Schmidli, H.
    METHODS OF INFORMATION IN MEDICINE, 2010, 49 (06) : 618 - 624
  • [6] Sample Size Reassessment in Non-inferiority Trials
    Friede, T.
    Kieser, M.
    METHODS OF INFORMATION IN MEDICINE, 2011, 50 (03) : 237 - 243
  • [7] Sample size for simultaneous testing of rate differences in non-inferiority trials with multiple endpoints
    Song, James X.
    COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2009, 53 (04) : 1201 - 1207
  • [8] Practical guide to sample size calculations: non-inferiority and equivalence trials
    Flight, Laura
    Julious, Steven A.
    PHARMACEUTICAL STATISTICS, 2016, 15 (01) : 80 - 89
  • [9] Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes
    Turner, Rebecca. M. M.
    Clements, Michelle. N. N.
    Quartagno, Matteo
    Cornelius, Victoria
    Cro, Suzie
    Ford, Deborah
    Tweed, Conor. D. D.
    Walker, A. Sarah
    White, Ian. R. R.
    STATISTICS IN MEDICINE, 2023, 42 (08) : 1127 - 1138
  • [10] A group sequential type design for three-arm non-inferiority trials with binary endpoints
    Li, Gang
    Gao, Shan
    BIOMETRICAL JOURNAL, 2010, 52 (04) : 504 - 518